Recalls / Active ingredient / Denosumab
Denosumab
2 FDA drug recalls involving the active ingredient “Denosumab”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2025-04-21 | Class II | PROLIA (denosumab), injection, 60mg/mL, For Subcutaneous Use Only, Rx Only, Manufactured by: Amgen Inc., Thous | Mckesson Medical-Surgical Inc. Corporate Office |
| 2013-09-17 | Class II | Prolia (denosumab) Injection, 60 mg/mL, 1 x 60 mg Single Use Prefilled Syringe per carton, Rx only, Manufactur | Amgen, Inc. |